December marked a milestone moment for FH Europe Foundation, closing an exceptional year of advocacy, collaboration and policy impact with the adoption of the European Safe Hearts Plan. From major EU-level developments to global engagement, patient leadership and research recognition, the month reinforced a shared commitment to prevention, early diagnosis and patient-centred cardiovascular care as … Continue reading FHEF December 2025 Edition Heart Beat Newsletter
The European Alliance for Cardiovascular Health (EACH) Summit, held in Brussels on December 11 to 12, brought together policymakers, clinicians, researchers, patient leaders, industry stakeholders, and life sciences representatives for two days of strategic dialogue aimed at accelerating progress against Europe’s leading cause of mortality: cardiovascular disease (CVD). The purpose of the Summit was clear: mobilise actionable momentum … Continue reading EACH Summit 2025: Advancing a Unified Vision for Cardiovascular Health in Europe
After years of discussion, negotiation, and political debate, the European Union has reached a milestone moment for medicines policy. The revision of EU pharmaceutical legislation—first launched by the European Commission in 2020 and formally proposed in 2023—has now reached a political agreement between EU institutions. This reform is widely recognised as the most far-reaching overhaul … Continue reading What the New EU Pharmaceutical Legislation Means for Patients
